Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation
Authors
Keywords
-
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 347, Issue -, Pages 449-459
Publisher
Elsevier BV
Online
2022-05-20
DOI
10.1016/j.jconrel.2022.05.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
- (2021) Hyeong Min Kim et al. Pharmaceutics
- A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina
- (2021) Guoxin Tan et al. Acta Biomaterialia
- Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis
- (2021) Marta Silva et al. ADVANCED DRUG DELIVERY REVIEWS
- Polymeric hydrogel as a vitreous substitute: current research, challenges, and future directions
- (2021) Ting Wang et al. Biomedical Materials
- Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update
- (2021) Mariacristina Parravano et al. BIODRUGS
- Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
- (2021) Aira Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in ocular drug delivery systems
- (2020) Jennifer J. Kang-Mieler et al. EYE
- Preclinical challenges for developing long acting intravitreal medicines
- (2020) Sahar Awwad et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Injectable biodegradable bi-layered capsule for sustained delivery of bevacizumab in treating wet age-related macular degeneration
- (2020) Pengfei Jiang et al. JOURNAL OF CONTROLLED RELEASE
- Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
- (2020) Rubén Varela-Fernández et al. Pharmaceutics
- Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins
- (2020) Armin Vedadghavami et al. Nano Today
- Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration
- (2019) Fangfang Qiu et al. MOLECULAR PHARMACEUTICS
- The gap between the need for novel retinal drug delivery methods, technologies in R&D phase, and approved ocular drug delivery technologies
- (2019) Ron Neumann et al. DRUG DISCOVERY TODAY
- Octopus-like Flexible Vector for Noninvasive Intraocular Delivery of Short Interfering Nucleic Acids
- (2019) Kuan Jiang et al. NANO LETTERS
- Drug delivery devices for retinal diseases
- (2018) Hirokazu Kaji et al. ADVANCED DRUG DELIVERY REVIEWS
- In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
- (2018) Karen Peynshaert et al. ADVANCED DRUG DELIVERY REVIEWS
- Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
- (2018) Whitney Shatz et al. Expert Opinion on Drug Delivery
- Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles
- (2017) Yongchao Chu et al. International Journal of Nanomedicine
- Prevalence of Age-Related Macular Degeneration in Europe
- (2017) Johanna M. Colijn et al. OPHTHALMOLOGY
- Visual tracing of diffusion and biodistribution for amphiphilic cationic nanoparticles using photoacoustic imaging after ex vivo intravitreal injections
- (2016) Xu Xu et al. International Journal of Nanomedicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started